Search

everythinglearnresearchcommunity

for

Search:↓

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

BeauTop improves hair growth in androgenetic alopecia patients.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Biotin deficiency in patients on total parenteral nutrition can cause serious symptoms but can be treated with biotin supplements.

Telogen effluvium is a common hair loss condition requiring careful diagnosis and treatment.

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.

Truncated LTBP-1 disrupts TGF-β signaling, affecting hair growth.

Using tacalcitol ointment with photodynamic therapy may effectively treat follicular mucinosis with scalp hair loss.

BD 1/4 dilution is the best for treating localized alopecia areata in adults.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

DNCB is more effective than betamethasone for hair regrowth but has more side effects.

Tofacitinib effectively and safely promotes hair regrowth in alopecia patients.

Dithranol is more effective than Tacrolimus for hair regrowth in alopecia areata.

The man's occipital hair loss was due to temporal triangular alopecia, not alopecia areata.

Terminalia bellirica extracts effectively promote hair regrowth and treat androgenetic alopecia.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

A child was initially wrongly diagnosed with a fungal scalp infection but actually had a non-scarring hair loss condition called Temporal Triangular Alopecia.

Using β-cyclodextrin derivatives improves the solubility and bioavailability of steroidal drugs.

Behavioral therapies are more effective than drugs for treating trichotillomania.

The new treatment showed promise in managing eyebrow hair loss.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.